Sugimachi K - Search Results

1

Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.

Kawahara N, Tanaka T, Yokomizo A, Nanri H, Ono M, Wada M, Kohno K, Takenaka K, Sugimachi K, Kuwano M. Kawahara N, et al. Among authors: sugimachi k. Cancer Res. 1996 Dec 1;56(23):5330-3. Cancer Res. 1996. PMID: 8968078

2

ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. Sugio K, et al. Among authors: sugimachi k. Cancer Res. 1992 May 15;52(10):2903-6. Cancer Res. 1992. PMID: 1581907

3

Flavone acetic acid increases the antitumor effect of hyperthermia in mice.

Sakaguchi Y, Maehara Y, Baba H, Kusumoto T, Sugimachi K, Newman RA. Sakaguchi Y, et al. Among authors: sugimachi k. Cancer Res. 1992 Jun 15;52(12):3306-9. Cancer Res. 1992. PMID: 1596889

4

Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time.

Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, Sugimachi K. Maehara Y, et al. Among authors: sugimachi k. Cancer. 1992 Jul 15;70(2):392-5. doi: 10.1002/1097-0142(19920715)70:2<392::aid-cncr2820700204>3.0.co;2-p. Cancer. 1992. PMID: 1617589

5

Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.

Kusumoto H, Maehara Y, Yoshida M, Takahashi I, Anai H, Sugimachi K. Kusumoto H, et al. Among authors: sugimachi k. Anticancer Drugs. 1992 Feb;3(1):33-8. doi: 10.1097/00001813-199202000-00006. Anticancer Drugs. 1992. PMID: 1623213

6

DNA polymerase-alpha as a putative early relapse marker in non-small cell lung cancer. An immunohistochemical study.

Tateishi M, Ishida T, Mitsudomi T, Sugimachi K. Tateishi M, et al. Among authors: sugimachi k. Cancer. 1991 Sep 1;68(5):925-9. doi: 10.1002/1097-0142(19910901)68:5<925::aid-cncr2820680502>3.0.co;2-r. Cancer. 1991. PMID: 1655217

7

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma.

Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K. Tateishi M, et al. Among authors: sugimachi k. Eur J Cancer. 1991;27(11):1372-5. doi: 10.1016/0277-5379(91)90012-3. Eur J Cancer. 1991. PMID: 1683776

8

Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer.

Kaneko S, Ishida T, Sugio K, Yokoyama H, Sugimachi K. Kaneko S, et al. Among authors: sugimachi k. Cancer Res. 1991 Aug 1;51(15):4008-11. Cancer Res. 1991. PMID: 1713125

9

Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma.

Kakeji Y, Tsujitani S, Mori M, Maehara Y, Sugimachi K. Kakeji Y, et al. Among authors: sugimachi k. Cancer. 1991 Dec 1;68(11):2438-42. doi: 10.1002/1097-0142(19911201)68:11<2438::aid-cncr2820681119>3.0.co;2-#. Cancer. 1991. PMID: 1718583

10

Superficial flat-type early carcinoma of the stomach.

Mori M, Adachi Y, Kakeji Y, Korenaga D, Sugimachi K, Motooka M, Ooiwa T. Mori M, et al. Among authors: sugimachi k. Cancer. 1992 Jan 15;69(2):306-13. doi: 10.1002/1097-0142(19920115)69:2<306::aid-cncr2820690206>3.0.co;2-7. Cancer. 1992. PMID: 1728361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,963 results

Search Page

Filters